| Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers A Sharma, SK Subudhi, J Blando, J Scutti, L Vence, J Wargo, JP Allison, ... Clinical Cancer Research 25 (4), 1233-1238, 2019 | 461 | 2019 |
| α-Pinene isolated from Schinus terebinthifolius Raddi (Anacardiaceae) induces apoptosis and confers antimetastatic protection in a melanoma model AL Matsuo, CR Figueiredo, DC Arruda, FV Pereira, JAB Scutti, ... Biochemical and biophysical research communications 411 (2), 449-454, 2011 | 251 | 2011 |
| Jacaranone induces apoptosis in melanoma cells via ROS-mediated downregulation of Akt and p38 MAPK activation and displays antitumor activity in vivo MH Massaoka, AL Matsuo, CR Figueiredo, CF Farias, N Girola, ... PLoS One 7 (6), e38698, 2012 | 78 | 2012 |
| Pyrostegia venusta heptane extract containing saturated aliphatic hydrocarbons induces apoptosis on B16F10-Nex2 melanoma cells and displays antitumor activity in vivo CR Figueiredo, AL Matsuo, FV Pereira, AN Rabaca, CF Farias, N Girola, ... Pharmacognosy magazine 10 (Suppl 2), S363, 2014 | 40 | 2014 |
| Anti‐metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10 FM De Melo, CJM Braga, FV Pereira, JT Maricato, CST Origassa, ... Immunology and cell biology 93 (1), 86-98, 2015 | 37 | 2015 |
| Role of SOCS-1 gene on melanoma cell growth and tumor development JAB Scutti, AL Matsuo, FV Pereira, MH Massaoka, CR Figueiredo, ... Translational oncology 4 (2), 101-109, 2011 | 36 | 2011 |
| A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies FV Pereira, CA Ferreira-Guimaraes, T Paschoalin, JAB Scutti, FM Melo, ... PLoS One 9 (4), e96141, 2014 | 27 | 2014 |
| SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression R Berzaghi, VSC Maia, FV Pereira, FM Melo, MS Guedes, CST Origassa, ... Scientific reports 7 (1), 40585, 2017 | 19 | 2017 |
| TLR4-mediated immunomodulatory properties of the bacterial metalloprotease arazyme in preclinical tumor models FV Pereira, ACL Melo, FM de Melo, D Mourão-Sá, P Silva, R Berzaghi, ... Oncoimmunology 5 (7), e1178420, 2016 | 14 | 2016 |
| Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa JAB Scutti International Journal of Oncology 52 (4), 1041-1056, 2018 | 13 | 2018 |
| Carcinoma de células escamosas de cabeça e pescoço (HNSCC): desvendando os mistérios do microambiente tumoral JAB Scutti, M Pineda, E Emerick Jr, ER Almeida Revista da Associacao Paulista de Cirurgioes Dentistas 70 (2), 156-163, 2016 | 11 | 2016 |
| Melanoma: perspectives of a vaccine based on peptides MH Massaoka, AL Matsuo, JAB Scutti, DC Arruda, AN Rabaça, ... Molecular Vaccines: From Prophylaxis to Therapy-Volume 1, 397-412, 2013 | 5 | 2013 |
| Resiquimod, a Toll-like receptor agonist promotes melanoma regression by enhancing plasmacytoid dendritic cells and T cytotoxic activity as a vaccination adjuvant and by direct … JAB Scutti, LM Vence, RE Royal, TC Wray, JN Cormier, JE Lee, A Lucci, ... Cancer Research 78 (13_Supplement), 614-614, 2018 | 4 | 2018 |
| A novel WT1-derived peptide induces cellular senescence and inhibits tumor growth in a human melanoma cell line and xenograft model MH Massaoka, AL Matsuo, FV Pereira, CR Figueiredo, JA Scutti, N Girola, ... Cancer Research 72 (8_Supplement), 2867-2867, 2012 | 2 | 2012 |
| Durable Responses with Ipilimumab Plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies IF Khouri, JAB Scutti, DR Milton, C Nicholas, M Pineda, EJ Jabbour, ... Blood 132, 4585, 2018 | 1 | 2018 |
| Immune Checkpoint Blockade and Immune Monitoring JA Scutti, R Luiz Immunoregulatory Aspects of Immunotherapy, 31-65, 2018 | 1 | 2018 |
| Erratum: SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression R Berzaghi, VSC Maia, FV Pereira, FM Melo, MS Guedes, CST Origassa, ... Scientific Reports 7, 42827, 2017 | | 2017 |
| Head and neck squamous cell carcinoma (HNSCC): unmasking the tumor microenvironment JAB Scutti, M Pineda, E Emerick Jr, ER Almeida Revista da Associacao Paulista de Cirurgioes Dentistas 70 (2), 156-163, 2016 | | 2016 |
| Phosphoethanolamine and cancer pills: how far is the horizon? JABS Scutti Houston Medical Times 1 (April), 3 and 16, 2016 | | 2016 |
| The tumor microenvironment in melanoma: Challenges and opportunities for immunotherapy JABS Scutti Houston Medical Times 1 (March), 7 and 22, 2016 | | 2016 |
